Financials
- Market Capitalization 12.2 B
- Employee 9 900
- Founded N/A
- CEO Jeffrey N. Simmons
- Website www.elanco.com
- Headquarter Indiana, United States
- FIGI BBG00LJYS1P8
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-61.52
Relación precio/flujo de caja
2.59
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 606 | VTRS Viatris Inc. - Common Stock | 16.94 USD | -0.88% | +0.06% | -4.83% | +63.67% | 19.46 B USD | ||
| 676 | NBIX Neurocrine Biosciences, Inc. - Common Stock | 158.35 USD | +0.35% | +1.56% | -6.05% | +9.21% | 16.10 B USD | ||
| 915 | RDY Dr. Reddy's Laboratories Ltd | 12.03 USD | -1.07% | -2.43% | -1.31% | -15.70% | 10.04 B USD | ||
| 1063 | ALKS Alkermes plc - Ordinary Shares | 46.88 USD | -1.76% | -3.97% | -6.61% | +62.27% | 7.86 B USD |